RT Journal Article
SR Electronic
T1 1356 DM926, a novel anti-LILRB1/LILRB2 dual antagonist antibody, promotes adaptive and innate immune response to enhance anti-tumor activity in preclinical models
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1510
OP A1510
DO 10.1136/jitc-2023-SITC2023.1356
VO 11
IS Suppl 1
A1 Hu, Guangan
A1 Zhao, Quanju
A1 Chen, Xiaochun
A1 Jiang, Xiaodong
A1 Xu, Yi
A1 Chang, Hong
A1 Yin, Sheng
A1 Bing, Nan
A1 Zhang, Dong
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1510.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.